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The role of nicotine as a determinant of cigarette 
smoking frequency in man with observations of certain 
cardiovascular effects associated with the tobacco alkaloid 
The effect of intravenously administered nicotine upon smoking behavior was studied in 
smokers who were unaware of the nature of the administered drug and the true purpose of 
the study. Smoking behavior was not altered significantly when nicotine was administered 
in a dose of 1 mg. per hour for 6 hours. A significant decrease in smoking frequency was 
obtained when nicotine was administered at the rate of 2 to 4 mg. per hour. Recordings of 
systolic blood pressure, heart rate, and the elect1"Ocardiogram indicate that the physiological 
alterations in these parameters produced by smoking can be reproduced by parenteral nicotine. 
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Larson, Haag, and Silvette6 have sum-
marized the literature concerning tobacco 
habituation and have listed the possible 
reasons for smoking in five main categories: 
( 1) for the pharmacological effects of nico-
tine; (2) for stimulation of special senses 
by other constituents of tobacco smoke; 
( 3) for psychological, psychic, or psycho-
analytic reasons; (4) for social and cul-
tural reasons; and (5) for economic rea-
sons. Lewin7 has stated, "the decisive fac-
tor in the effects of tobacco, desired or un-
desired, is nicotine and it matters little 
whether it passes directly into the orga-
nism or is smoked." 
Of the many chemical substances pres-
ent in tobacco smoke, nicotine is the only 
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substance known to produce acute phar-
macological effects. Johnston5 first admin-
istered nicotine parenterally to smokers in 
an effort to satisfy their craving for tobacco 
and reported that his patients were disin-
clined to smoke for a time following the 
administration of the alkaloid. Similarly, 
Ejrup and Wikander2 reported that some 
heavy smokers, receiving increasing dos-
ages of nicotine, 6 to 18 mg., for 10 days, 
felt satisfied and saturated and could only 
take a few puffs on a cigarette or stopped 
entirely. Finnegan, Larson, and Haag-' re-
ported that inveterate smokers experienced 
different reactions to smoking low-nicotine 
cigarettes, hut they became adapted to the 
change in 1 to 2 weeks. The authors con-
cluded that with many smokers nicotine 
became a major factor in the cigarette 
habit, but in others nicotine was not of the 
same importance. More recently, Ejrup/ 
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in discussing the role of nicotine in smok-
ing pleasure and ways of breaking the 
cigarette habit, has suggested that injec-
tions of nicotine or a nicotine derivative 
such as lobeline be employed to reduce or 
eliminate the physiological part of the 
withdrawal symptoms experienced when 
smokers are denied the use of tobacco. 
The limited number of studies on the 
role of nicotine in the smoking habit tend 
to suggest that it has an influence on an 
individual's desire for tobacco. The avail-
able studies, however, suffer from the fact 
that both subject and investigator were 
aware of the objectives of the study, and 
in many instances the subjects had ex-
pressed a desire to be assisted in their ef-
forts to break the smoking habit. The pres-
ent investigation was undertaken to eval-
uate the role of nicotine upon the smoking 
behavior in human volunteers who were 
unaware of the true objectives of the study. 
The subjects employed in this study were 
in excellent physical health as determined 
by medical examination and were not con-
templating breaking their smoking habit. 
Method 
The studies were done on volunteers, 
man and women ranging in age between 
21 and 30 years. Candidates for the study 
were selected after having passed a com-
plete medical and psychiatric examination. 
Each subject was studied for fifteen con-
secutive days; each experimental session 
lasted exactly 6 hours. 
The subjects were instructed to abstain 
from food, beverages, and tobacco from 
midnight of the day preceding the experi-
mental session. The subjects arrived at the 
laboratory at 7 :30 A.M. and were permitted 
to rest in the reclining position for 30 min-
utes before having their blood pressure 
and heart rate recorded in both the supine 
and sitting positions. The subjects were 
then put in a sound-proof, air-conditioned 
isolation booth. Electrodes for recording 
the electrocardiogram or heart rate were 
attached, as was a Beckman pulse pickup 
and blood pressure cuff for registration of 
Clinical Pharmacology 
and Therapeutics 
the blood pressure. A 23 gauge scalp-vein 
hypodermic needle was inserted into a 
suitable forearm vein and fixed in place. 
The intravenous needle was connected to 
a Y-adapter and two sterile extension tubes 
that were led to the outside of the cubicle. 
Each tube was connected to a Holter 
Micro Bilateral Roller pump; the flow in 
each of the tubes could be varied inde-
pendently. One pump delivered 0.9 per 
cent sodium chloride continuously through-
out the 6 hour session. The other pump 
was used for the administration of nicotine 
or saline solution. Drug administration 
could thus be carried out without the sub-
ject being aware. The cardiac rate was re-
corded continuously; the blood pressure 
and electrocardiogram were recorded every 
15 minutes on a Beckman-Offner Dyno-
graph located outside the isolation cubicle. 
During their period of confinement in 
the cubicle, the subjects were permitted 
to have a standardized breakfast and lunch 
and were allowed to smoke at any time. 
Throughout the 6 hour experimental ses-
sion the volunteers were assigned a variety 
of psychological testing procedures-time 
estimation, reaction time, and hand steadi-
ness tests. The daily schedule was repeated 
in an identical manner on each of the fif-
teen experimental days. The number of 
cigarettes consumed during each of the 
sessions was recorded. In addition, the re-
maining portions· of the cigarettes were 
collected and weighed at the end of each 
day. 
Each subject received a trial intravenous 
infusion of nicotine bitartrate in which the 
dosage of nicotine ranged from 0.5 to 4 
mg. per hour. These preliminary studies 
were carried out with the subjects in the 
supine position after an 8 hour fast. The 
subjects were unaware of the drug being 
administered and were instructed to report 
all subjective responses. The studies re-
ported here were performed on subjects 
capable of tolerating the 4 mg. per hour 
dose of nicotine without subjective re-
sponses. 
The experiments were designed so that 
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each subject had experimental sessions in 
which he received an intravenous infusion 
of 0.9 per cent sodium chloride (control 
sessions) and sessions in which nicotine 
bitartrate was administered (drug ses-
sions ). The sequence of control and nico-
tine administration sessions was selected 
randomly. 
Results 
Effects of intravenous nicotine on smok-
ing frequency. Each of 4 men received 
nicotine bitartrate in a dose of 1 mg. over 
a 20 minute period which was repeated 
after 40 minutes. Thus, a total of 6 mg. of 
nicotine was administered by intermittent 
intravenous infusion in the course of 6 
hours. Control sessions of equal duration 
were conducted in which the subjects re-
ceived 0.9 per cent sodium chloride 
throughout the course of the experimental 
session. No statistically significant differ-
ence could be demonstrated between the 
number of cigarettes smoked during the 
control sessions versus the drug-adminis-
tration sessions. 
The mode of drug administration was al-
tered in 5 additional subjects; they re-
ceived 2 mg. of nicotine in the first hour 
and 4 mg. per hour for each of the next 
5 hours. Thus, in the course of 6 hours 
each subject received a total of 22 mg. of 
nicotine intravenously. The results are 
summarized in Table I which shows the 
average number of cigarettes consumed 
during the saline-control and drug-admin-
istration sessions in each of 5 volunteers. 
There was a significant decrease in the 
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average number of cigarettes smoked by 
each of the subjects receiving 22 mg. of 
nicotine over a 6 hour period. The aver-
age decrease in the number of cigarettes 
smoked per subject was 2.7 ± 0.4. 
In addition to a reduction in the total 
number of cigarettes smoked by each sub-
ject receiving intravenous nicotine, there 
was a decrease in the amount of each 
cigarette smoked. The data in Table II 
show the residual weights of the cigarettes 
for each volunteer during saline control 
and drug infusion sessions. The residual 
weights of the cigarettes smoked during 
the nicotine administration sessions were 
greater than the residual weights of the 
cigarettes smoked during the saline con-
trol sessions. The differences were statis-
tically Significant and further suggest that 
the intravenous administration of nicotine 
decreases the motivation to smoke. 
The act of smoking is, associated with 
periodic inhalations of nicotine-containing 
smoke which results in phasic increases in 
nicotine absorption from the oral and pul-
monary membranes. An attempt was made 
to infuse nicotine in a manner which 
would deliver 1 mg. of the alkaloid period-
ically over a duration of 14 minutes. The 
procedure was stopped for 32 minutes and 
repeated again for an additional 14 min-
utes and continued in this manner for the 
6 hour session. Thus, the subjects received 
a total of 8 mg. per day of nicotine on 
this regimen. A significant decrease in the 
number of cigarettes smoked was obtained 
in 3 of 4 subjects. The data are summarized 
in Fig. 1. Subject 7 failed to demonstrate 
Table I. Comparison of average number of cigarettes consumed per six hour 
session under saline control and drug conditions 
Saline control Drug 
No. of 
I I 
No. of 
I I Level of Subiect sessions Mean ± S.E. sessions Mean ± S.E. significance 
1 7 17.9 ±0.72 7 14.4 ± 0.58 <0.005 
2 4 7.0 ±O 5 4.4 ± 0.24 <0.0005 
3 6 7.3 ± 0.40 6 4.8 ± 0.48 <0.005 
4 7 11.4 ± 0.52 5 8.2 ± 0.32 <0.005 
5 5 6.7 ± 0.25 4 4.7 ±0.25 <0.005 
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Table II. Comparison of residual weights 
of cigarettes consumed under saline control 
and drug conditions 
Mean weight (Gm.) 
Saline 
I 
Level of 
Subfect control Drug significance 
1 0.4196 0.4671 <0.025 
2 0.6165 0.7430 <0.005 
4 0.5100 0.5669 <0.05 
5 0.5448 0.6292 <0.005 
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Fig. 1. Average number of cigarettes consumed 
per 6 hour session under saline control and two 
nicotine administration conditions. Drugp condi-
tion represents the periodic infusion of 8 mg. per 
day. Drug condition represents the continuous in-
fusion of 12 mg. per day. Brackets represent the 
standard error of the mean. 
a change in smoking frequency when given 
8 mg. of nicotine per day, but showed a 
Significant decrease when the administered 
dose was increased to 12 mg. per day on 
the continuous regimen. Subject 9, how-
ever, showed the same decrease in smoking 
frequency on either the periodic schedule 
of 8 mg. per day or the continuous admin-
istration of 12 mg. per day. 
Cardiovascular effects associated with 
smoking and/or the intravenous adminis-
tration of nicotine. The heart-rate changes 
produced by smoking or by smoking plus 
the intravenous administration of nicotine 
(22 mg. in 6 hours) are presented in Fig. 
2. The mean cardiac rate in 5 subjects, 
taken with the subjects at rest seated in 
the isolation cubicle, was 72 ± 3.3 beats 
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Fig. 2. Mean heart rate per hour interval for 5 
subjects under saline control and nicotine admin-
istration conditions. 
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Fig. 3. Mean heart rate per hour interval for one 
subject under smoking and no smoking conditions. 
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Fig. 4. Mean heart rate per hour interval for one 
subject smoking one cigarette per hour for 3.5 
hours. Each point represents 3 determinations. 
per minute. One hour after the start of the 
experimental session in which the subjects 
received only saline intravenously, the 
mean heart rate was 84 ± 2.8 beats per 
minute. The increase in rate was associated 
with the smoking of the first cigarette in 
each of the 5 subjects. At the end of 6 
hours the mean heart rate obtained during 
saline control sessions was 84 ± 2.9 beats 
per minute. There was no difference in the 
magnitude of the heart rate increase in the 
same 5 subjects when they were given nic-
otine (22 mg.) during the 6 hour experi-
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Fig. 5. Changes in cardiac rhythm induced by the infusion of 1 mg. (upper tracing) and 
4 mg. (lower tI"acing) of nicotine. The middle tracing shows cardiac l'hythm changes elicited 
by smoking the first cigarette of the day. 
mental session. After the first hour, with 
the subjects smoking and having received 
2 mg. of nicotine, the average heart rate 
was 88 ± 2.6 beats per minute, which was 
not significantly different from that seen 
when the subjects smoked during periods 
of saline administration. Similarly, at the 
end of 6 hours after a cumulative dose of 
22 mg. of nicotine, the mean heart rate was 
85 ± 3.7 beats per minute. 
That the increase in heart rate was due 
to smoking was demonstrated by compar-
ing the heart rate of one subject during 
five experimental sessions when smoking 
was permitted with identical experimental 
sessions when smoking was not permitted. 
The data are illustrated in Fig. 3. There is 
a significant elevation in heart rate asso-
ciated with smoking. Likewise, Fig. 4 
shows the effect obtained when an experi-
mental subject was permitted to smoke 
after the first 2.5 hours of the experimental 
session. There is an abrupt increase in 
heart rate associated with the smoking of 
the first cigarette. 
The results indicate that the heart-rate 
changes observed in these studies were 
associated with the act of smoking and not 
related to the activities of the subject dur-
ing confinement in the isolation cubicle. 
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Fig. 6. Control electrocardiogram from a nonsmoker subject. The second set of tracings for 
each experimental day show changes in cardiac rhythm associated with smoking one cigarette. 
The time indicates the number of minutes from the onset of smoking. HR represents heart 
rate in beats per minute. 
The increase in heart rate occurs after the 
first cigarette of the day and remains ele-
vated as long as the individual continues 
to smoke. The administration of nicotine 
(22 mg. in 6 hours) did not increase the 
heart rate above that produced by smoking 
alone. 
The changes in blood pressure were also 
associated with the use of tobacco. Systolic 
blood pressure increased significantly after 
the initial cigarette regardless of whether 
saline or nicotine was being administered. 
The diastolic pressure showed less of a 
tendency to increase. The end result was 
an increased pulse pressure. The average 
resting systolic pressure in 5 subjects was 
no mm. Hg at the start of the experi-
mental session, whereas after smoking for 
6 hours or smoking plus intravenous nico-
tine the average systolic pressure was 130 
mm.Hg. 
Electrocardiographic changes associated 
with smoking or the intravenous adminis-
tration of nicotine were observed in 2 vol-
unteers. Fig. 5 shows the EKG recordings 
from the same subject on three separate 
days. The rhythm changes illustrated in 
the upper and lower tracings were asso-
ciated with the intravenous administration 
of nicotine, 1 and 4 mg. respectively. The 
bigeminy seen in the second set of tracings 
occurred 4 minutes after the subject had 
started to smoke the first cigarette of the 
day. It was of interest to note that subse-
quent cigarettes or continued intravenous 
administration of nicotine did not cause 
alterations in cardiac rhythm. Repeated 
twelve-lead electrocardiographic tracings 
showed the individual to be free of dis-
turbances of cardiac rhythm or conduction. 
The ECG tracings in Fig. 6 were ob-
tained from a nonsmoker who volunteered 
to smoke one cigarette while resting in the 
supine position. The control tracings were 
obtained after the subject had rested for 
30 minutes. The lower tracings of each 
pair were obtained while the subject 
smoked a cigarette. On each of two days 
smoking was associated with the develop-
ment of coupled beats which subsided 
within 30 minutes after smoking was dis-
continued. Fig. 6 also illustrates the marked 
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increase in heart rate produced by one 
cigarette. 
Discussion 
The habitual use of tobacco is related pri-
marily to psychological and social drives, 
reinforced and perpetuated by the phar-
macological actions of nicotine on the cen-
tral nervous system, the latter being inter-
preted subjectively either as stimulating 
or tranquilizing dependent upon the in-
dividual response. ll The importance of 
nicotine in the cigarette habit has been 
suspected and subjected to study by a 
number of investigators. As demonstrated 
by Johnston,5 it is possible to mimic the 
subjective effects of smoking by the par-
enteral or oral administration of nicotine. 
These experiments, although lacking in 
suitable experimental design and experi-
mental controls, suggested that the mo-
tivation to smoke was reduced during the 
administration of nicotine. The study by 
Finnegan, Larson, and Haag3 further 
emphasized the role of nicotine by demon-
strating that smokers can detect a reduc-
tion in nicotine content of cigarettes and 
that in some individuals a cigarette con-
taining no nicotine would be grudgingly 
accepted as better than no cigarette at all. 
The latter observation is supported by the 
fact that denicotinized tobacco has not 
found general public acceptance as a sub-
stitute.6 
The present investigation attempted to 
determine if the smoking habit was related 
to a general craving for the pharmacolog-
ical effects of nicotine in subjects who 
were unaware of the nature of the admin-
istered drug or the true purpose of the 
studies. The doses of nicotine used were 
in the range which did not produce sub-
jective effects; this made it possible to ran-
domly alternate between nicotine and 
saline infusions in the same subject. The 
results obtained suggest that nicotine plays 
a small but significant role in the smoking 
habit and that part of the craving for a 
cigarette can be satisfied by the intrave-
nous administration of the alkaloid. This 
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was manifested by a reduction in the num-
ber of cigarettes consumed and by a re-
duction in the amount of each cigarette 
smoked by subjects receiving intravenous 
nicotine. 
Smoking is a form of dry distillation, 
during which the nicotine is partially de-
stroyed by the heat of combustion. Part of 
the vapor is condensed in the cooler re-
gions of the cigarette. The smoke which is 
inhaled is referred to as the mainstream 
smoke and that which is given off to the 
environment is called the sidestream 
smoke. The standard cigarette with a 
weight of 1 Gm. contains approximately 20 
mg. of nicotine. The data of Pierce" O and 
that of Harlan and Mosekey4 indicate that 
the mainstream smoke from one cigarette 
contains from 1.2 to 3 mg. of nicotine. 
Therefore, the dose of nicotine of 4 mg. 
per hour intravenously would be equiva-
lent to the amount of the alkaloid absorbed 
systemically during the smoking of one or 
two standard cigarettes per hour. Thus, if 
the pleasure of smoking or craving for to-
bacco were due to the general effects of 
the alkaloid we should have observed a 
much greater reduction in the smoking fre-
quency. As suggested by Ejrup,l the phys-
iological effect of nicotine may be general 
or local. The experimental design used in 
this study did not permit an evaluation of 
the importance of the local effects of nico-
tine in the smoking habit. 
The results of the psychological testing 
procedures, while not presented in this 
publication, are of significance. The paren-
teral administration of nicotine did not al-
ter the performances of the subjects in 
any of the testing procedures. This would 
suggest that the ability of nicotine to de-
press cigarette-smoking frequency is a spe-
cific effect and not a generalized behav-
ioral action of the alkaloid. 
The effects of smoking and nicotine 
upon the cardiovascular system have been 
covered in many excellent studies and have 
been summarized by Larson, Haag, and 
Silvette.6 The effects of cigarette smoking 
upon the heart rate and blood pressure 
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were of interest in that increases in both 
parameters occurred immediately with the 
first cigarette of the day and were main-
tained throughout the day as long as the 
subject continued to smoke. The electro-
cardiographic changes noted in subject 
M. R. S. (Fig. 5) occurred during the 
smoking of the first one or two cigarettes 
or during the initial administration of in-
travenous nicotine. The electrocardio-
graphic alterations were less prominent 
and absent as subsequent cigarettes were 
consumed. It is important to stress that in 
each instance the subjects had abstained 
from smoking for a minimum of 8 hours. 
Therefore, we were in a position to ob-
serve the acute effects of smoking or nico-
tine upon the cardiovascular system. In the 
majority of healthy subjects neither smok-
ing nor the intravenous injection of nico-
tine produces any pathological electrocar-
diographic changes.9 At times extrasystoles, 
occasionally coupled, can occur as a 
result of nicotine in healthy subjects as 
well as in the presence of cardiac 
pathology.s." The subjects showing elec-
trocardiographic changes in heart rhythm 
were considered to be in good health and 
had electrocardiographic examinations 
which were considered to be within nor-
mal limits. 
The authors are indebted to Dr. Merle Law-
rence of the Kresge Hearing Research Institute 
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for providing the laboratory facilities required for 
this study. 
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